| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author index
|
|
|
|
213 |
S2 |
p. S42-S46
|
artikel
|
| 2 |
Copyright
|
|
|
|
213 |
S2 |
p. iii
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
213 |
S2 |
p. i
|
artikel
|
| 4 |
OC-16: Comparison of VTE recurrence, bleeding-related hospitalization and all-cause mortality in patients with active cancer in two patient populations, based upon cancer types considered to have high and low risks of bleeding, receiving DOACs or LMWH: The OSCAR UK Study
|
Cohen, A.T.
|
|
|
213 |
S2 |
p. S9-S10
|
artikel
|
| 5 |
OC-07: Contact pathway activation and risk of venous thromboembolism in patients with pancreatic cancer: the prospective SENECA study
|
Bosch, F.T.M.
|
|
|
213 |
S2 |
p. S4
|
artikel
|
| 6 |
OC-13: Differentially expressed coagulome genes (DECGs) are prognostic in breast cancer
|
Tinholt, M.
|
|
|
213 |
S2 |
p. S7-S8
|
artikel
|
| 7 |
OC-14: Effectiveness and safety of 6-months' treatment with different full-dose enoxaparin regimens in patients with cancer-associated venous thromboembolism: a subgroup analysis of the RIETECAT cohort study
|
Monreal, M.
|
|
|
213 |
S2 |
p. S8-S9
|
artikel
|
| 8 |
OC-06: Identification of predictive hemostatic biomarkers for cancer diagnosis: results from the HYPERCAN study
|
Gamba, S.
|
|
|
213 |
S2 |
p. S3-S4
|
artikel
|
| 9 |
OC-01: Mortality impact of cancer-associated venous thromboembolism: final analysis from Oncothromb12-01 study
|
Ruiz, M.
|
|
|
213 |
S2 |
p. S1
|
artikel
|
| 10 |
OC-04: Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress
|
Cedervall, J.
|
|
|
213 |
S2 |
p. S2-S3
|
artikel
|
| 11 |
OC-02: Outcomes of cancer-associated isolated superficial vein thrombosis in daily practice
|
Langer, F.
|
|
|
213 |
S2 |
p. S1-S2
|
artikel
|
| 12 |
OC-10: Plasmatic von Willebrand factor encapsulates blood circulating melanoma cells to prevent their hematogenous metastasis
|
Wang, Y.
|
|
|
213 |
S2 |
p. S6
|
artikel
|
| 13 |
OC-03: Platelet-derived von Willebrand factor is involved in thrombosis and metastatic growth of melanoma in the brain
|
Schneider, S.W.
|
|
|
213 |
S2 |
p. S2
|
artikel
|
| 14 |
OC-09: Rivaroxaban compared to no treatment in early breast cancer patients (the TIP Trial): initial findings for a phase II preoperative window-of-opportunity randomised controlled trial
|
Kirwan, C.C.
|
|
|
213 |
S2 |
p. S5-S6
|
artikel
|
| 15 |
OC-11: Safety and efficacy of apixaban as thromboprophylaxis in multiple myeloma patients receiving chemotherapy: a prospective cohort study
|
Sayar, Z.
|
|
|
213 |
S2 |
p. S6-S7
|
artikel
|
| 16 |
OC-12: Stroke and risk of cancer: a Danish population-based cohort study
|
Skajaa, N.
|
|
|
213 |
S2 |
p. S7
|
artikel
|
| 17 |
OC-15: Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers (TARGET-TP); a randomized trial
|
Alexander, M.
|
|
|
213 |
S2 |
p. S9
|
artikel
|
| 18 |
OC-08: The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors
|
Overvad, T.F.
|
|
|
213 |
S2 |
p. S4-S5
|
artikel
|
| 19 |
OC-05: Thromboembolism after incident colorectal cancer in the Netherlands: incidence, predictors, and prognosis
|
Anijs, R.J.S.
|
|
|
213 |
S2 |
p. S3
|
artikel
|
| 20 |
PO-35: A method for prioritisation and translation of pleiotropic effects into clinical applications: lessons from low molecular weight heparin treatment in cancer
|
Heald, A.
|
|
|
213 |
S2 |
p. S27
|
artikel
|
| 21 |
PO-38: A new armamentarium choice in cancer-associated upper-limb vein thrombosis resistant to heparin: a clinical case of seminoma in BEP chemotherapy protocol solved with edoxaban
|
Fioretti, A.M.
|
|
|
213 |
S2 |
p. S28-S29
|
artikel
|
| 22 |
PO-34: Antiplatelet and cytostatic properties of nilotinib synthetic analogues
|
Pechlivani, L.M.
|
|
|
213 |
S2 |
p. S26-S27
|
artikel
|
| 23 |
PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer
|
Englisch, C.
|
|
|
213 |
S2 |
p. S12
|
artikel
|
| 24 |
PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients
|
Haque, F.
|
|
|
213 |
S2 |
p. S28
|
artikel
|
| 25 |
PO-45: Cancer-associated thrombosis (CAT) in gynecological cancers: data from ACT4CAT study
|
Tsoukalas, N.
|
|
|
213 |
S2 |
p. S32
|
artikel
|
| 26 |
PO-42: Cancer-associated thrombosis (CAT): to which extent are cancer patients educated about their increased risk, and which factors determine if prophylaxis is realized - results of a patients' survey
|
Kranefeld, J.
|
|
|
213 |
S2 |
p. S30
|
artikel
|
| 27 |
PO-41: Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?
|
Petit, B.
|
|
|
213 |
S2 |
p. S30
|
artikel
|
| 28 |
PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry
|
Antonucci, E.
|
|
|
213 |
S2 |
p. S39
|
artikel
|
| 29 |
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms
|
Kelliher, S.
|
|
|
213 |
S2 |
p. S14-S15
|
artikel
|
| 30 |
PO-30: Chemotherapeutic agents temozolomide and lomustine induce procoagulant activity of glioblastoma cell lines in vitro
|
Kapteijn, M.Y.
|
|
|
213 |
S2 |
p. S24
|
artikel
|
| 31 |
PO-29: Coagulation and circulating tumour cells as pharmacodynamic biomarkers of response to aromatase inhibitors in breast cancer
|
Kirwan, C.C.
|
|
|
213 |
S2 |
p. S24
|
artikel
|
| 32 |
PO-48: Coagulopathy in multiple myeloma
|
Chasakova, K.
|
|
|
213 |
S2 |
p. S33-S34
|
artikel
|
| 33 |
PO-60: Comparison of inferior vena cava (IVC) filter use and outcomes between cancer and non-cancer patients in a single-center cohort
|
Lopez, N.
|
|
|
213 |
S2 |
p. S40
|
artikel
|
| 34 |
PO-05: D-dimers cut off level to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma
|
Charles, S.
|
|
|
213 |
S2 |
p. S13
|
artikel
|
| 35 |
PO-59: Dealing with pediatric cancer associated thrombosis: a case report and a monocentric cohort study
|
Campello, E.
|
|
|
213 |
S2 |
p. S39-S40
|
artikel
|
| 36 |
PO-26: Development of a spontaneous model for cancer-associated thrombosis
|
Ünlü, B.
|
|
|
213 |
S2 |
p. S22-S23
|
artikel
|
| 37 |
PO-61: Direct oral anticoagulants (DOAC) in cancer associated thrombosis (CAT): experience of thrombosis clinic of tertiary cancer institute
|
Daddi, A.
|
|
|
213 |
S2 |
p. S40-S41
|
artikel
|
| 38 |
PO-63: Edoxaban effect in a breast cancer patient with liver arterial infusion chemotherapy (LAIC) and both jugular vein and hepatic artery thrombosis: a unique clinical case
|
Fioretti, A.M.
|
|
|
213 |
S2 |
p. S41-S42
|
artikel
|
| 39 |
PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study
|
López-Núñez, J.J.
|
|
|
213 |
S2 |
p. S37-S38
|
artikel
|
| 40 |
PO-25: Elevated plasma von Willebrand Factor in patients with breast cancer may contribute to the early metastatic niche, promoting endothelial adhesion, invasion and angiogenic properties of circulating breast cancer cells
|
Patmore, S.
|
|
|
213 |
S2 |
p. S22
|
artikel
|
| 41 |
PO-49: Genomic determinants and clinical relevance of cancer- associated thrombosis in biliary tract cancers
|
Provenzano, L.
|
|
|
213 |
S2 |
p. S34
|
artikel
|
| 42 |
PO-62: Improves oral anticoagulation controls and quality of life in by remote control compared to traditional controls in oncological thrombosis in the pediatric population
|
Martos, R.
|
|
|
213 |
S2 |
p. S41
|
artikel
|
| 43 |
PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study
|
Albertsen, I.E.
|
|
|
213 |
S2 |
p. S21-S22
|
artikel
|
| 44 |
PO-20: Incidence of venous thromboembolism in patients with BRAF-mutated colorectal cancer
|
Morán, L. Ortega
|
|
|
213 |
S2 |
p. S20
|
artikel
|
| 45 |
PO-28: Investigating the relationship between a stromal wound healing phenotype and breast density as a mechanism for breast cancer development
|
Ogunlayi, H.
|
|
|
213 |
S2 |
p. S23
|
artikel
|
| 46 |
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery
|
Tesakov, I.P.
|
|
|
213 |
S2 |
p. S35
|
artikel
|
| 47 |
PO-01: KRAS mutation in colorectal cancer and risk of venous thromboembolism: a Danish population-based cohort study
|
Troelsen, F.S.
|
|
|
213 |
S2 |
p. S11
|
artikel
|
| 48 |
PO-13: Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
|
Muster, V.
|
|
|
213 |
S2 |
p. S16-S17
|
artikel
|
| 49 |
PO-56: Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis: CAT-LONG study
|
Lopez-Ruz, S.
|
|
|
213 |
S2 |
p. S38
|
artikel
|
| 50 |
PO-50: Molecular landscape of the coagulome of oral squamous cell carcinoma
|
Lottin, M.
|
|
|
213 |
S2 |
p. S34-S35
|
artikel
|
| 51 |
PO-02: Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients
|
Jakobsen, S.S.
|
|
|
213 |
S2 |
p. S11-S12
|
artikel
|
| 52 |
PO-18: Myocardial infarction and risk of cancer
|
Petersen, J.D.
|
|
|
213 |
S2 |
p. S19
|
artikel
|
| 53 |
PO-52: Neutrophil tissue factor is increased in essential thrombocythemia
|
Reeves, B.N.
|
|
|
213 |
S2 |
p. S35-S36
|
artikel
|
| 54 |
PO-46: Perception of the risk of thrombosis in clinicians treating patients with multiple myeloma
|
Marcos-Jubilar, M.
|
|
|
213 |
S2 |
p. S32-S33
|
artikel
|
| 55 |
PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study
|
Donadini, M.P.
|
|
|
213 |
S2 |
p. S30-S31
|
artikel
|
| 56 |
PO-21: PICC vs. Port in patients with hematologic malignancies
|
Fidalgo, N. Pérez
|
|
|
213 |
S2 |
p. S20-S21
|
artikel
|
| 57 |
PO-27: Platelet-cancer cell hetero-aggregate formation is sustained by fibrin polymerization initiated on the cancer cell surface, and platelet entrapment into the fibrin network
|
Tesakov, I.P.
|
|
|
213 |
S2 |
p. S23
|
artikel
|
| 58 |
PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study
|
Salgado, M.
|
|
|
213 |
S2 |
p. S36-S37
|
artikel
|
| 59 |
PO-16: Prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
|
Hsu, C.
|
|
|
213 |
S2 |
p. S18
|
artikel
|
| 60 |
PO-47: Prevention and treatment of recurrent trombosis after reconstruction of major vessels
|
Chernyak, V.
|
|
|
213 |
S2 |
p. S33
|
artikel
|
| 61 |
PO-07: Procoagulant extracellular vesicles in patients with different types of acute leukemia
|
Hisada, Y.
|
|
|
213 |
S2 |
p. S14
|
artikel
|
| 62 |
PO-53: Prostate cancer and the increased risk of deep vein thrombosis: case report
|
Shorova, M.
|
|
|
213 |
S2 |
p. S36
|
artikel
|
| 63 |
PO-10: Rate of thrombosis and bleeding after urological surgery under standardized anticoagulation
|
Cordes, J.
|
|
|
213 |
S2 |
p. S15-S16
|
artikel
|
| 64 |
PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study
|
Daguenet, E.
|
|
|
213 |
S2 |
p. S21
|
artikel
|
| 65 |
PO-14: Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients
|
Silva-Cardenas, D.C.
|
|
|
213 |
S2 |
p. S17
|
artikel
|
| 66 |
PO-33: Real-world VTE and implemented treatments in patients with cancer: an observational study in the French EGB database
|
Mahé, I.
|
|
|
213 |
S2 |
p. S25-S26
|
artikel
|
| 67 |
PO-44: Risk assessment model potency to detect patients most likely to benefit from thromboprophylaxis: an application of the TARGET- TP score
|
Alexander, M.
|
|
|
213 |
S2 |
p. S31-S32
|
artikel
|
| 68 |
PO-12: Risk of bleeding after surgery for colorectal cancer in type 2 diabetes patients: a Danish population-based cohort study
|
Kristensen, F.P.
|
|
|
213 |
S2 |
p. S16
|
artikel
|
| 69 |
PO-09: Risk of intracranial hemorrhage of direct oral anticoagulants (DOACs) versus low molecular weight heparin (LMWH) in brain cancers: a meta-analysis of comparative studies
|
Haddad, P.
|
|
|
213 |
S2 |
p. S15
|
artikel
|
| 70 |
PO-11: Risk of major bleeding in cancer patients with ischemic stroke treated with thrombolysis
|
Skajaa, N.
|
|
|
213 |
S2 |
p. S16
|
artikel
|
| 71 |
PO-32: Rivaroxaban targets the hypercoagulant tumour microenvironment to reduce primary tumour growth and stem cell activity in oestrogen receptor positive breast cancer murine models
|
Blower, E.L.
|
|
|
213 |
S2 |
p. S25
|
artikel
|
| 72 |
PO-17: Socioeconomic position and the risk of occult cancer in venous thromboembolism
|
Jørgensen, H.
|
|
|
213 |
S2 |
p. S18-S19
|
artikel
|
| 73 |
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients
|
Grammoustianou, M.
|
|
|
213 |
S2 |
p. S29
|
artikel
|
| 74 |
PO-36: The impact of oral anticoagulant drugs for arterial thromboembolism in patients with cancer
|
Foresta, A.
|
|
|
213 |
S2 |
p. S27-S28
|
artikel
|
| 75 |
PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)
|
Dimakakos, E.
|
|
|
213 |
S2 |
p. S29
|
artikel
|
| 76 |
PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression
|
Mäder, J.
|
|
|
213 |
S2 |
p. S25
|
artikel
|
| 77 |
PO-04: Thrombin generation and D-dimer significantly predict for early disease progression and mortality in patients with gastrointestinal cancer
|
Giaccherini, C.
|
|
|
213 |
S2 |
p. S12-S13
|
artikel
|
| 78 |
PO-06: Thrombomodulin as a marker for VTE following neoadjuvant chemotherapy
|
Ward, M.P.
|
|
|
213 |
S2 |
p. S13-S14
|
artikel
|
| 79 |
PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment
|
Dimakakos, E.
|
|
|
213 |
S2 |
p. S17-S18
|
artikel
|
| 80 |
PO-23: Upper extremity deep vein thrombosis in cancer patients: our experience
|
Mangiacapra, S.
|
|
|
213 |
S2 |
p. S21
|
artikel
|
| 81 |
PO-19: Venous and arterial thromboembolism in pancreatic neuroendocrine neoplasms
|
Gervaso, L.
|
|
|
213 |
S2 |
p. S19-S20
|
artikel
|
| 82 |
PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients
|
Martín, A. Muñoz
|
|
|
213 |
S2 |
p. S38-S39
|
artikel
|
| 83 |
Title Page
|
|
|
|
213 |
S2 |
p. v
|
artikel
|
Tijdschrift beschrijving